Focal dystonia, which includes cervical dystonia (a condition in which the neck muscles contract involuntarily) and blepharospasm (a condition in which there are abnormal contractions or twitches of the eyelid), affect 295 million people in the United States. These conditions along with wrinkles are now being treated with the neurotoxin botulinum. Botulinum works by relaxing wrinkle-causing muscle contractions. Conventional treatments for these conditions had been microdermabrasion, chemical peels, face lifts, and bow lifts. These therapies have some down time and are not necessarily long lasting. Botulinum, however, treats the root of the problem and lasts for months at a time. Botox, a brand name of botulinum, is a popular product that is synonymous with wrinkle removal.
Xeomin, another brand name of botulinum is a newer FDA approved drug for these conditions. Xeomin does the same thing as the popular Botox. What Xeomin has to offer over Botox is that experts have found Xeomin has the ability to last slightly longer than Botox and is less expensive than Botox, making it readily avaliable to a larger population of people. In addition to being less costly than Botox, Xeomin is “naked,” meaning it contains no additives other than botulinum toxin type A. The reason why this is significant is because the human body creates antibodies when it senses foreign invaders. The body can sometimes associate Botox as a foreign invader and create antibodies to combat its intended purpose. The fact that Xeomin contains nothing other than botulinum allows it to carry out its purpose in the body and to produce the desired result.